PacificHealth Laboratories, Inc.
PHLI
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 1.72M | 2.23M | 1.75M | 966.40K | 1.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.72M | 2.23M | 1.75M | 966.40K | 1.97M |
| Cost of Revenue | 1.14M | 1.36M | 1.01M | 594.90K | 1.12M |
| Gross Profit | 585.10K | 866.10K | 744.20K | 371.40K | 850.80K |
| SG&A Expenses | 906.50K | 913.30K | 762.70K | 853.20K | 944.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06M | 2.29M | 1.79M | 1.45M | 2.08M |
| Operating Income | -337.90K | -65.60K | -35.50K | -488.20K | -109.40K |
| Income Before Tax | -345.40K | -69.70K | -39.80K | -488.60K | -116.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -345.40K | -69.70K | -39.80K | -488.60K | -116.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -345.40K | -69.70K | -39.80K | -488.60K | -116.70K |
| EBIT | -337.90K | -65.60K | -35.50K | -488.20K | -109.40K |
| EBITDA | -314.00K | -42.80K | -25.30K | -479.50K | -100.10K |
| EPS Basic | -0.02 | 0.00 | 0.00 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 20.87M | 20.87M | 20.87M | 20.87M | 20.87M |
| Average Diluted Shares Outstanding | 20.87M | 20.87M | 20.87M | 20.87M | 20.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
